First-Line High-Dose Chemotherapy for ’Poor Risk’ Metastatic Non-Seminomatous Testicular Germ Cell Tumors

Publisher： Karger

E-ISSN： 2296-5262|21|2|23-25

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.21, Iss.2, 1998-06, pp. : 23-25

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Can a Cure Be Achieved with Taxane-Based Chemotherapy plus Surgery in Patients with Primary Mediastinal Non-Seminomatous Germ Cell Tumors and Progression or Relapse Despite First-Line Chemotherapy?

By  

Oncology Research and Treatment, Vol. 33, Iss. 3, 2010-02 ,pp. : 119-120

Karger

Access to resources Recommend Favorite

Current Trends in Chemotherapy for Metastatic Nonseminomatous Testicular Germ Cell Tumors

By  

Oncology, Vol. 55, Iss. 3, 1998-04 ,pp. : 177-188

Karger

Access to resources Recommend Favorite

Patterns of Relapse after Chemotherapy in Patients with High-Risk Non-Seminomatous Germ Cell Tumor

By  

Oncology, Vol. 78, Iss. 1, 2010-03 ,pp. : 47-53

Karger

Access to resources Recommend Favorite

Two Cases of Cerebral Sinus Venous Thrombosis Following Chemotherapy for Non-Seminomatous Germ Cell Tumor

By  

Case Reports in Oncology, Vol. 4, Iss. 3, 2011-11 ,pp. : 555-559

Karger

Access to resources Recommend Favorite

The Management of Stage I Nonseminomatous Testicular Germ Cell Tumors

By  

Oncology, Vol. 71, Iss. 3-4, 2007-07 ,pp. : 151-158

Karger

Access to resources Recommend Favorite